Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 12Active not recruiting 10Completed 4Terminated 3Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 19Breast Neoplasms 11Lung Neoplasms 10Brain Neoplasms 9Glioblastoma 7Neoplasm Metastasis 6Neoplasms 5Glioma 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Sarcoma 4Pancreatic Neoplasms 4Head and Neck Neoplasms 4Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Mycosis Fungoides 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Liver Neoplasms 3Gliosarcoma 3Waldenstrom Macroglobulinemia 2Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Sezary Syndrome 2Rectal Neoplasms 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroendocrine Tumors 2

Interventions

Gemcitabine 25Cisplatin 19pembrolizumab 11avelumab 10Nivolumab 7Mitomycin 6Carboplatin 6apaziquone 5Paclitaxel 5Vinblastine 4Methotrexate 4Doxorubicin 4Docetaxel 4BCG Vaccine 4vofatamab 3durvalumab 3atezolizumab 3Sunitinib 3Standard of Care 3Sorafenib 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Radiation 3Magnetic Resonance Spectroscopy 3Lapatinib 3Cystectomy 3B701 protein, Human herpesvirus 6 3valrubicin 2rucaparib 2enfortumab vedotin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Urinary Bladder Neoplasms × Magnetic Resonance Spectroscopy × Clear all
NCT04936230 2025-08-17

Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
1 enrolled 1 chart
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03007719 2020-01-21

Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1

University of California, San Francisco

Phase 2 Terminated
4 enrolled 8 charts
Genitourinary

Urinary Bladder Neoplasms

NCT00147238 2012-08-07

A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast

M.D. Anderson Cancer Center

Phase NA Terminated
10 enrolled 3 charts
Genitourinary

Urinary Bladder Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡